# Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

> **NCT00419484** · — · COMPLETED · sponsor: **Dokkyo Medical University** · enrollment: 1000 (—)

## Conditions studied

- Type 2 Diabetes
- Hypertension
- Dyslipidemia
- Diabetic Nephropathy

## Interventions

- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT00419484
- **Lead sponsor:** Dokkyo Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 1000 (—)
- **Last updated:** 2007-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419484, "Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT00419484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*